2BB score and signals
Amicus Therapeutics, Inc.’s current 2BB score is 17 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 100 | Very Strong |
2BBBullish & Bearish
Amicus Therapeutics, Inc. (FOLD) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 17 out of 100.
Amicus Therapeutics, Inc.’s current 2BB score is 17 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 100 | Very Strong |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-07-29 | — | 0.0825 | — | $185.81M |
| 2026-04-29 | — | 0.0323 | — | $165.25M |
| 2026-02-19 | — | 0.0885 | — | $184.30M |